Harmony Biosciences Holdings, Inc. (HRMY) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Valor IV Pharma Holdings, LLC entity

10% owner

—

$139.39M (2)

−$139.39M

0

0.0000%

$0.00

—

Marshman Fund Trust II entity

10% owner

$8.15M (1)

$139.39M (2)

−$131.24M

6,051,120

10.39%

$260.53M

−3.7%

Andreas Wicki

Director

—

$127.30M (29)

−$127.30M

2,147,943

3.69%

$92.48M

−53.7%

Jack Nielsen

Director

$1.21M (6)

$96.52M (68)

−$95.31M

2,613,726

4.49%

$112.53M

−39.8%

Jeffrey Dierks

Chief Commercial Officer

—

$11.90M (38) scheduled

−$11.90M

0

0.0000%

$0.00

−100.0%

John C Jacobs

President, CEO

—

$8.78M (16) scheduled

−$8.78M

0

0.0000%

$0.00

—

Jeffrey M. Dayno

President, CEO

—

$5.43M (13) scheduled

−$5.43M

7,346

0.0126%

$316.28K

—

Sandip Kapadia

Chief Financial Officer

—

$3.89M (9) scheduled

−$3.89M

24,521

0.0421%

$1.06M

+2,452,000%

Novo Holdings A/S entity

10% owner

$3.18M (1)

—

+$3.18M

4,409,803

7.57%

$189.86M

—

Kumar Budur

Chief Medical Officer

—

$3.11M (7) scheduled

−$3.11M

13,115

0.0225%

$564.66K

+1,205%

Andrew Serafin

Chief Strategy Officer

—

$2.29M (2) scheduled

−$2.29M

1,474

0.0025%

$63.46K

—

Jeffrey S Aronin

Director

—

251,922

0.4326%

$10.85M

—

Adam H. Zaeske

Chief Commercial Officer

—

4,327

0.0074%

$186.30K

—

Harmony Biosciences Holdings, Inc.

What the insiders did Net selling

By person